Hey guys, I'm a newbie to bioinformatics and still doing an undergrad. But I really needed help with something and hope you guys can. I am designing an expression vector using APE and needed to know about how to engineer the ribosome binding site into it. I'm sorry if this is a really dumb question but like I said, complete newbie.
-
-
For this exercise you may want to resort to a low tech (pen and paper/talking this through with someone in person) method. Especially if you are new to informatics and do not have adequate biology background. Only you know what kind resources (vectors/fragments/enzymes) are available in the lab you are working in and unless you provide a lot of additional information it may not be possible for folks here to help.
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment